Cardiovascular disease in patients requiring NIV for ECOPD.

N. Lane (Newcastle upon Tyne, United Kingdom), T. Hartley (Newcastle upon Tyne, United Kingdom), J. Steer (Newcastle upon Tyne, United Kingdom), M. Elliott (Leeds, United Kingdom), M. Sovani (Nottingham, United Kingdom), H. Curtis (Gateshead, United Kingdom), E. Fuller (South Tyneside, United Kingdom), P. Murphy (London, United Kingdom), D. Shrikrishna (Taunton, United Kingdom), K. Lewis (Wales, United Kingdom), N. Ward (Plymouth, United Kingdom), C. Turnbull (Oxford, United Kingdom), V. Ferguson (Newcastle upon Tyne, United Kingdom), N. Hart (London, United Kingdom), S. Bourke (Newcastle upon Tyne, United Kingdom)

Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Session: Cardiovascular comorbidities in COPD
Session type: Thematic Poster
Number: 2655
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Lane (Newcastle upon Tyne, United Kingdom), T. Hartley (Newcastle upon Tyne, United Kingdom), J. Steer (Newcastle upon Tyne, United Kingdom), M. Elliott (Leeds, United Kingdom), M. Sovani (Nottingham, United Kingdom), H. Curtis (Gateshead, United Kingdom), E. Fuller (South Tyneside, United Kingdom), P. Murphy (London, United Kingdom), D. Shrikrishna (Taunton, United Kingdom), K. Lewis (Wales, United Kingdom), N. Ward (Plymouth, United Kingdom), C. Turnbull (Oxford, United Kingdom), V. Ferguson (Newcastle upon Tyne, United Kingdom), N. Hart (London, United Kingdom), S. Bourke (Newcastle upon Tyne, United Kingdom). Cardiovascular disease in patients requiring NIV for ECOPD.. 2655

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Exacerbations and mortality of COPD patients with cardiovascular disease in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

Cardiovascular failure versus infectious disease as causes of exacerbation of COPD in a respiratory ICU
Source: Eur Respir J 2006; 28: Suppl. 50, 179s
Year: 2006

Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


COPD as undetected cause of dyspnea in patients admitted with ischaemic heart disease (IHD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Cardiovascular events (CVE) in COPD patients
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011

Outpatient care for reducing readmissions of patients hospitalized for exacerbation of COPD
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Cardiovascular comorbidity in severe COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


Predicting mortality in patients hospitalised with acute exacerbations of COPD (AECOPD) requiring assisted ventilation
Source: Annual Congress 2012 - New scientific findings on noninvasive ventilation in the acute setting
Year: 2012



Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive?
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013


Cardiovascular comorbidity predictors of survival in patients with COPD hypercapnic acute respiratory failure
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016

Real-life experience of older patients requiring NIV for exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure
Year: 2009

Impact of Co-morbidities on the outcome of Noninvasive ventilation (NIV) in patients of COPD patients with hypercarbic respiratory failure.
Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure
Year: 2017

Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013